Hot Pursuit     16-Feb-23
Alembic Pharma gains as Karkhadi facility gets EIR from USFDA
Alembic Pharmaceuticals rose 1.02% to Rs 507.05 after the pharma company received an Establishment Inspection Report (EIR) from the US drug regulator for the inspection carried out at its injectable facility at Karkhadi.
The US Food and Drug Administration (USFDA) conducted the pre-approval inspection from 18 August 2022 to 30 August 2022, for ANDAs filed by the company.

The company said that it has already started receiving ANDA approvals manufactured at Karkhadi facility.

Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company. The company manufactures and markets generic pharmaceutical products all over the world.

The drug maker reported 29% drop in consolidated net profit to Rs 121.92 crore despite a 18.7% rise in net sales to Rs 1509.02 crore in Q3 FY23 over Q3 FY22.

Previous News
  Alembic Pharmaceuticals consolidated net profit rises 48.01% in the December 2023 quarter
 ( Results - Announcements 05-Feb-24   14:52 )
  Alembic Pharma rises on USFDA nod for breast cancer drug
 ( Hot Pursuit - 01-Apr-24   13:52 )
  Alembic Pharma gets USFDA nod for Icatibant injection
 ( Hot Pursuit - 17-Jun-24   14:03 )
  Volumes soar at Lemon Tree Hotels Ltd counter
 ( Hot Pursuit - 02-Jan-24   11:00 )
  Alembic Pharmaceuticals reports consolidated net profit of Rs 120.60 crore in the June 2023 quarter
 ( Results - Announcements 04-Aug-23   14:15 )
  Alembic Pharma suspends Sikkim facility operations due to floods
 ( Hot Pursuit - 04-Oct-23   14:39 )
  Alembic Pharmaceuticals to convene board meeting
 ( Corporate News - 18-Jan-23   10:51 )
  Alembic Pharmaceuticals to conduct AGM
 ( Corporate News - 20-Sep-22   16:05 )
  Alembic Pharma gets tentative USFDA nod for Brexpiprazole tablets
 ( Hot Pursuit - 09-Mar-23   09:18 )
  Alembic Pharmaceuticals consolidated net profit declines 85.86% in the March 2022 quarter
 ( Results - Announcements 02-May-22   16:33 )
  Alembic Pharmaceuticals receives USFDA approval for various products
 ( Corporate News - 09-May-24   09:01 )
Other Stories
  Eicher Motors CV sales rises 11% YoY in June’24
  01-Jul-24   15:39
  Atul Auto hits record high as sales double to 2,628 units in Jun’24
  01-Jul-24   15:29
  Ashok Leyland slides as total sales slips 2% YoY in June'24
  01-Jul-24   15:16
  Reliance Infrastructure Ltd leads losers in 'A' group
  01-Jul-24   15:00
  Oriental Carbon & Chemicals Ltd leads losers in 'B' group
  01-Jul-24   14:45
  Rane Holdings hits life high on plan to acquire 51% stake in JV
  01-Jul-24   14:45
  Maruti Suzuki rises as total sales jumps 12% YoY in Jun’24
  01-Jul-24   14:37
  Volumes jump at Emami Ltd counter
  01-Jul-24   14:30
  Karur Vysya Bank advances climb 16% YoY in Jun'24
  01-Jul-24   14:14
  SML Isuzu jumps as June sales surges 38% YoY
  01-Jul-24   14:13
Back Top